Real-World Outcomes of Brexucabtagene Autoleucel ( brexu-cel) for Relapsed or Refractory (R/R) Adult B-Cell Acute Lymphoblastic Leukemia (B-cell ALL): Evidence from the CIBMTR Registry-MedSci.cn

Real-World Outcomes of Brexucabtagene Autoleucel ( brexu-cel) for Relapsed or Refractory (R/R) Adult B-Cell Acute Lymphoblastic Leukemia (B-cell ALL): Evidence from the CIBMTR Registry

Bezerra, E; Itani, T; Wudhikarn, K; Perales, MA; Yang, Y; Gergis, U; Aribi, A; Hill, LC; Jain, N; Leonard, JT; Lutfi, F; Kim, S; Bye, M; Wang, HL; Hadjivassileva, T; Nikolaenko, L; Kloos, I; Abdeldaim, A; Dalton, D; Xu, HR; Pasquini, M; Kebriaei, P

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务